👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
Trust score 8/100
Accepting new patients
Dr
Dr James Price
Oncology
English
3,843+
Patients seen
2
Years in practice
7
Publications
1
Languages spoken
About
Dr. Price is an experienced clinical oncologist. He graduated from the University of Sheffield in 2009. After completing his specialty training in Nottingham in 2018, he relocated to The Christie in Manchester to pursue a fellowship in proton beam therapy. In January 2020, he was appointed to a PhD research fellowship focusing on oropharyngeal cancers (cancers of the tonsils, tongue, or throat) and became a Consultant Clinical Oncologist in May 2020. He specialises in treating head and neck cancers using advanced radiotherapy techniques, including IMRT, VMAT, and IGRT, as well as proton beam therapy (IMPT).
Dr. Price has a strong interest in research and serves as the radiotherapy quality assurance lead for the UK phase 3 TORPEdO trial (IMPT vs IMRT for reducing toxicity in oropharyngeal cancer) and the PROTIS trial (IMPT vs IMRT for treating sinonasal cancer). His other research interests include improving patient selection for (chemo)radiotherapy through mathematical models and using advanced imaging techniques to predict treatment outcomes.
Dr. Price is the clinical lead for implementing electronic patient-reported outcomes (ePROMs) across clinical teams at The Christie and serves as the medical lead for alcohol and smoking services within the Trust. Additionally, he is a Clinical and Educational supervisor for Clinical Oncology trainees and an examiner for the Royal College of Radiologists.
Dr. Price has a strong interest in research and serves as the radiotherapy quality assurance lead for the UK phase 3 TORPEdO trial (IMPT vs IMRT for reducing toxicity in oropharyngeal cancer) and the PROTIS trial (IMPT vs IMRT for treating sinonasal cancer). His other research interests include improving patient selection for (chemo)radiotherapy through mathematical models and using advanced imaging techniques to predict treatment outcomes.
Dr. Price is the clinical lead for implementing electronic patient-reported outcomes (ePROMs) across clinical teams at The Christie and serves as the medical lead for alcohol and smoking services within the Trust. Additionally, he is a Clinical and Educational supervisor for Clinical Oncology trainees and an examiner for the Royal College of Radiologists.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr James Price
Education & training
-
2014–2020 MD · Medicine and Surgery
-
2020–2024 Residency · Oncology
Career & appointments
-
2024-09–2025-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
AmTrust Europe · 2,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 2,575 |
| Annual physical exam | 99395 | 2,361 |
| Vaccination administration | 90471 | 2,073 |
| Minor procedure (skin) | 17110 | 1,862 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 540.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 810.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 18 · i10: 9
-
Validation of clinical scoring in Oncology
DOI: 10.3859/euroclin.2026.0 · PMID: 31573977 · cited by 23
-
Long-term follow-up of Oncology across GB
DOI: 10.7284/euroclin.2025.1 · PMID: 32940979 · cited by 165
-
Validation of clinical scoring in Oncology
DOI: 10.3185/euroclin.2024.2 · PMID: 34933607 · cited by 67
-
Long-term follow-up of Oncology across GB
DOI: 10.7779/euroclin.2023.3 · PMID: 34131042 · cited by 121
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
Society memberships
- WONCA Europe — Family Doctors — Member · since 2025
- national college of family doctors — Member · since 2025
- European Union of Medical Specialists (UEMS) — Member · since 2025
Patient reviews
- Bedside Manner
- 0.05
- Knowledge
- 0.08
- Wait Time
- 3.80
- Staff Friendliness
- 0.02
- Ease Of Appointment
- 4.00
- Value For Money
- 4.10
- Would Recommend Pct
- 4
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · james.price@euroclinics.example
